Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × tyramine-deoxysorbitol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Cyclophosphamide 906 Carboplatin 781 Paclitaxel 740 pembrolizumab 721 Bevacizumab 713 Cisplatin 702 Gemcitabine 614 Docetaxel 578 Rituximab 555 Radiotherapy 540 Dexamethasone 506 Nivolumab 476 Doxorubicin 444 Fluorouracil 390 Capecitabine 382 Etoposide 358 Oxaliplatin 334 Pemetrexed 332 Cytarabine 331 Lenalidomide 326 Prednisone 325 Erlotinib Hydrochloride 322 fludarabine phosphate 314 Trastuzumab 302 Leucovorin 296 fludarabine 294 Vincristine 288 Bortezomib 283 Filgrastim 283 Cetuximab 273

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03248440 2021-08-05

SUNRISE

Senju USA, Inc.

Phase 3 Completed

263 enrolled 7 charts

Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡